News

Generics substitution: Ireland’s plan for reference pricing

Published on 2012/11/26

A bill that will be debated this autumn seeks to introduce generics substitution and reference pricing for medicines and medical and surgical appliances in Ireland. Painful medicine for the health se...

40 views

Read more →

ABPI concerned about medicines misconceptions

Published on 2012/11/23

The Association of the British Pharmaceutical Industry (ABPI) represents innovative research-based biopharmaceutical companies in the UK. In a new survey commissioned by the association issues of misu...

1 views

Read more →

Italian Medicines Agency publishes concept paper on biosimilars

Published on 2012/11/21

The Italian Medicines Agency (Agenzia Italiana del Farmaco, AIFA) announced on 1 August 2012 the release of a concept paper on biosimilars. The purpose of the concept paper on biosimilar drugs is to...

6 views

Read more →

Poor quality pharma ingredients abound in China

Published on 2012/11/19

Lack of regulatory enforcement in China is allowing poor quality pharmaceutical ingredients to be sold to drug manufacturers with potentially dangerous or even fatal consequences for patients. In Eur...

2 views

Read more →

India’s patent laws coming under repeated challenges

Published on 2012/11/15

India’s patent laws are being challenged by Big Pharma. Novartis is challenging India for denying the pharma giant a patent for Glivec (imatinib mesylate), its blockbuster cancer drug. While Bayer i...

8 views

Read more →

Maximising the potential of generics in Abu Dhabi

Published on 2012/11/13

IntroductionAll residents in Abu Dhabi have access to health care via mandatory health insurance. Nationals, who comprise 20% of the population with two-thirds under 30 years of age and half under 19 ...

17 views

Read more →

Coupons help Big Pharma to fend off generics

Published on 2012/11/08

Pfizer’s success at using co-pay coupons to prevent patients switching from brand-name products to generics is encouraging other pharmaceutical giants to follow suit. When its patent for the choles...

11 views

Read more →

Growing economies, growing markets: a bright future for biosimilars

Published on 2012/11/05

The biosimilars market, currently small and focused on a few disease areas and countries, is likely to grow considerably over the coming years, particularly in the US and emerging economies such as Br...

7 views

Read more →

Biosimilar comparability debate continues

Published on 2012/11/01

Authors Schellekens and Moors comment on the response from EMA’s Biosimilar Medicinal Products Working Party to questions that they raised regarding EMA’s comprehensive biosimilar regulatory pathw...

7 views

Read more →

Facts about generics for patients

Published on 2012/10/29

The costs of health care are rising across Europe through ageing populations resulting in more patients with chronic diseases, stricter clinical targets for managing patients with long term (chronic) ...

9 views

Read more →

Positioning of biosimilars: commodity versus differentiated

Published on 2012/10/25

How to market a new biosimilar is a key question, especially when taking into consideration the costs that are associated with developing a biosimilar. Whether the biosimilar will be a bulk (commodity...

39 views

Read more →

Generics reduce England’s drug spending

Published on 2012/10/22

According to a new report from the National Health Service in England, published on 31 July 2012, despite a 3.8% increase in the number of prescriptions dispensed in 2011 compared to 2010, spending o...

4 views

Read more →